Inhibition of the proliferation of cells of the multiple myeloma

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 7078478
SERIAL NO

10194985

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Multiple myeloma is treated by deletion mutants of the gp130 protein of the IL-3 receptor. These mutants inhibit the binding of Hck tyrosine kinase and the growth of tumor cells, particularly myeloma cells.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GSF-FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT GMBHTHE FEDERAL REPUBLIC OF GERMANY OBERSCHLEISSHEIM

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Hallek, Michael Schondorf, DE 62 623
Schaeffer, Michael Munich, DE 5 161
Schneiderbauer, Michaela Altoetting, DE 2 7
Weidler, Sascha Munich, DE 3 7

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation